Causes of Recurrent Pregnancy Loss
Recurrent pregnancy loss (RPL), defined as three or more consecutive pregnancy losses before 24 weeks gestation, is caused by genetic abnormalities (up to 60% of cases), antiphospholipid syndrome, uterine structural defects, endocrine disorders, and male factor contributions, though up to 75% of cases remain unexplained despite thorough evaluation. 1, 2, 3
Established Genetic Causes
Chromosomal abnormalities are the most common identifiable cause of RPL:
- Fetal chromosomal defects account for 50-60% of early miscarriages and are non-modifiable 4, 5
- Parental chromosomal rearrangements (translocations, inversions) should be identified through karyotyping of both partners 1
- Recurrent complete hydatidiform moles may indicate mutations in NLRP7 and KHDC3L genes, causing familial recurrent hydatidiform mole (FRHM), an autosomal recessive condition requiring genetic counseling 1, 5, 6
Autoimmune and Thrombotic Causes
Antiphospholipid antibody syndrome (APLA) is the primary autoimmune cause requiring treatment:
- Screen for lupus anticoagulant (LAC) and anticardiolipin antibodies (ACA) in all patients with three or more miscarriages before 10 weeks 1, 7
- APLA causes thrombosis in maternal circulation leading to fetal loss 7
- Treatment with unfractionated heparin or LMWH plus low-dose aspirin is recommended for confirmed APLA syndrome 1
Do NOT routinely screen for inherited thrombophilias (factor V Leiden, prothrombin G20210A, protein C/S deficiency) as they are not established causes of RPL 1, 6. The only exception: women with homozygous factor V Leiden or prothrombin 20210A mutation AND positive family history for VTE should receive antepartum LMWH prophylaxis—but this is for VTE prevention, not pregnancy loss prevention 1, 6.
Anatomical/Structural Causes
Uterine cavity abnormalities interfere with implantation and cause 14-38% of RPL cases:
- Congenital uterine anomalies (Müllerian anomalies) affect up to 38% of women with recurrent miscarriage 4, 6
- Intrauterine synechiae (adhesions) from prior infection or surgery 4, 6
- Cervical incompetence 4
- Evaluation approach: Start with transvaginal ultrasound (TVUS), then sonohysterography (SIS) for superior cavity assessment, or hysterosalpingography (HSG) as an alternative 1, 5, 6
Endocrine and Metabolic Causes
Hormonal dysfunction contributes significantly to RPL:
- Thyroid dysfunction requires TSH and free T4 testing with optimization before conception 1, 6
- Polycystic ovary syndrome (PCOS) is associated with higher pregnancy loss rates and should be evaluated 1, 6
- Insulin resistance and obesity increase miscarriage risk 4, 6
- Diminished ovarian reserve with severely reduced AMH levels may increase miscarriage risk 6
Male Factor Contributions
Male partner evaluation is now mandatory in couples with two or more pregnancy losses:
- Perform karyotype testing to identify chromosomal abnormalities 1, 6
- Consider sperm DNA fragmentation testing, as increasing evidence links elevated sperm DNA fragmentation with RPL 1, 6
- Abnormal male partner karyotype is an established contributing factor 6
Unexplained Causes
Idiopathic RPL represents the majority of cases:
- Up to 75% of RPL cases remain unexplained despite thorough evaluation 2, 8
- The long-term prognosis is generally good, with most couples eventually achieving a healthy live birth 8, 3
- Regular physical activity within guidelines is safe and may actually benefit insulin resistance and obesity, which increase miscarriage risk 4, 1, 6
Critical Pitfalls to Avoid
- Do not over-test for thrombophilias: Routine inherited thrombophilia screening is not indicated and wastes resources 1
- Do not use LMWH for prevention of recurrent fetal growth restriction: There is no evidence supporting this indication 6
- Do not count biochemical pregnancies only: RPL definition requires clinically recognized pregnancies (confirmed by ultrasound or hCG), including anembryonic pregnancies 5
- Do not neglect male partner evaluation: This is now a guideline recommendation after two or more losses 1, 6
Modifiable Risk Factors
Lifestyle modifications should be addressed in all patients: